The microtubule inhibiting agent epothilone B antagonizes glioma cell motility associated with reorganization of the actin-binding protein α-actinin 4

Oncology Reports

Volumn 25, Issue 3, 2011, Pages 887-893

  Henry, Whitney I ^a   Dubois, Juwen ^a   Quick, Quincy A ^a  

^a GRAMBLING STATE UNIVERSITY   (United States)

Author keywords

actinin 4; Epothilone B; Glioblastoma; Microtubule actin cross linking factor

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; ALPHA ACTININ 4; BINDING PROTEIN; EPOTHILONE B;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROTUBULE; PRIORITY JOURNAL; PROTEIN CROSS LINKING;

ACTININ; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL MOVEMENT; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; EPOTHILONES; GLIOMA; HUMANS; MICROFILAMENT PROTEINS; MICROTUBULES; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; TUBULIN MODULATORS; TUMOR CELLS, CULTURED;

EID: 79551581199     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1145     Document Type: Article

References (36)

1. Giese A, Bjerkvig R, Berens ME, et al: Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Ooncol 21: 1624-1636, 2003.
2. Hadfield JA, Ducki S, Hirst N, et al: Tubulin and microtubules as targets for anticancer drugs. Prog Cell Cycle Res 5: 309-325, 2003.
3. Mollinedo F and Gajate C: Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8: 413-450, 2003.
4. Honore Kamath K, Braguer D, et al: Ssynergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Cancer 64: 4957-4964, 2004.
5. Pellegrini F and Budman DR: Review: tubulin function, action of antitubulin drugs, and new drug development. Ccancer Invest 23: 264-273, 2005.
6. Zhou J and Giannakakou P: Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents 5: 65-71, 2005.
7. Dumontet C and Sikic BI: Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin 17: 1061-1070, 1999.
8. Dumontet C: Mechanisms of action and resistance to tubulin-binding agents. Expert Opin Investig Drugs 9: 779-788, 2000.
9. Fojo AT and Menefee M: Microtubule targeting agents: basic mechanisms of multidrug resistance (MDR). Ssemin 32 (Suppl. 7): S3-S8, 2005.
10. Quick Q: Epothilone B induces glioblastoma cell death via survivin down-regulation. Exp 30: 195-201, 2008.
11. Westerlund A, Hujanen E, Höyhtyä M, et al: Ovarian cancer cell invasion is inhibited by paclitaxel. Clin Exp Metastasis 15: 318-328, 1997.
12. Belotti D, Rieppi M, Nicoletti MI, et al: Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. 2: 1725-1730, 1996.
13. Tonn JC, Haugland HK, Saraste J, et al: Differential effects of vincristine and phenytoin on the proliferation, migration, and invasion of human glioma cell lines. J Neurosurg 82: 1035-1043, 1995.
14. Ogasawara M, Matsubara T and Suzuki H: Screening of natural compounds for inhibitory activity on colon cancer cell migration. Biol Pharm Bull 24: 720-723, 2001.
15. Pan Y, Jing Pitre A, Williams BJ and Skalli O: Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton. FASEB J 22: 3196-3206, 2008.
16. Quick Q and Skalli O: Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and Rrho A signaling of astrocytoma cells. Cell 316: 1137-1147, 2010.
17. Honda K, Yamada T, Endo et al: Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140: 1383-1393, 1998.
18. Honda K, Yamada T, Hayashida Y, et al: Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 128: 51-62, 2005.
19. Koizumi T, Nakatsuji H, Fukawa T, et al: The role of actinin-4 in bladder cancer invasion. Urol 75: 357-364, 2010.
20. Sen Dong M and Kumar S: Isoform-specific contributions of alpha-actinin to glioma cell mechanobiology. PLoS One 4: e8427, 1-9, 2009.
21. Barbolina MV, Adley BP, Kelly DL, et al: Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Lab Invest 88: 602-614, 2008.
22. Bijman MN, van Nieuw Amerongen GP, Laurens et al: Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton. Mol Cancer Ther 5: 2348-2357, 2006.
23. Rosenblum MD and Shivers RR: 'Rrings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere. Comp Biochem Physiol C Toxicol Pharmacol 125: 121-131, 2000.
24. Kodama A, Karakesisoglou I, Wong et al: ACF7: an essential integrator of microtubule dynamics. Cell 115: 343-354, 2003.
25. Wu X, Kodama A and Fuchs E: ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. Cell 135: 137-148, 2008.
26. Bernier G, Pool M and Kilcup M: Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development. Dev Dyn 219: 216-225, 2000.
27. Röper K, Gregory SL, Brown NH, et al: The 'spectraplakins': cytoskeletal giants with characteristics of both spectrin and plakin families. J Cell Sci 115: 4215-4225, 2002.
28. Sonnenberg A and Liem RK: Plakins in development and disease. 313: 2189-2203, 2007.
29. Etienne-Manneville S: Actin and microtubules in cell motility: which one is in control? Traffic 5: 470-477, 2004.
30. Giese A, Loo MA, Tran et al: Dichotomy of astrocytoma migration and proliferation. Iint J Cancer 67: 275-282, 1996.
31. McDonough W, Tran Giese A, et al: Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Neurol 57: 449-455, 1998.
32. Cheng KL, Bradley T and Budman DR: Novel microtubule-targeting agents - the epothilones. Biologics 2: 789-811, 2008.
33. Hayot C, Farinelle S, De Decker R, et al: In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton. Int J Oncol 21: 417-425, 2002.
34. Begley DJ: ABC transporters and the blood-brain barrier. Curr Pharm Des 10: 1295-1312, 2004.
35. Löscher W and Potschka H: Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2: 86-98, 2005.
36. Scherrmann JM: Expression and function of multidrug resistance transporters at the blood-brain barriers. Drug Metab Toxicol 1: 233-246, 2005.